Company profile
UK company 10238425, incorporated on 17 June 2016.
Takeda - Better Health, Brighter Future
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients.
Company number 10238425
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
GammaDelta Therapeutics is developing immunotherapeutic drugs, using gamma delta cells, to treat cancer and other diseases.
GammaDelta Therapeutics has received seed funding from the London based VC Abingworth and hast started its R&D program and translational work with a focus on GMP cell production. It currently employs 4 FTE scientists and is looking to increase this numbers to 12 by the end of 2017 whilst negotiating series A funding.
